Pediatric Interventional Cardiology Market
According to Intent Market Research, the Pediatric Interventional Cardiology Market is expected to grow from USD 1.3 Billion in 2024-e at a CAGR of 18.9% to touch USD 3.7 Billion by 2030. The Pediatric Interventional Cardiology Market is dominated by key players such as Abbott Laboratories, Medtronic, Boston Scientific Corporation, Edwards Lifesciences Corporation, Terumo Corporation, and Johnson & Johnson